We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$11.2B
AUM Growth
-$925M
Cap. Flow
-$880M
Cap. Flow %
-7.89%
Top 10 Hldgs %
15.04%
Holding
603
New
165
Increased
118
Reduced
122
Closed
159

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$155M
2
NXPI icon
NXP Semiconductors
NXPI
+$138M
3
CRM icon
Salesforce
CRM
+$124M
4
AKAM icon
Akamai
AKAM
+$114M
5
PF
Pinnacle Foods, Inc.
PF
+$113M

Sector Composition

Rank Sector Weight
1 Technology 18.82%
2 Industrials 16.36%
3 Energy 11.6%
4 Financials 11.57%
5 Healthcare 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTTB icon
351
Q32 Bio
QTTB
$464M
$2.04M 0.02%
5,556
-1,111
-17% -$398K
UTI icon
352
Universal Technical Institute
UTI
$1.59B
$2M 0.02%
634,291
+20,280
+3% +$62.3K
PBPB
353
DELISTED
Potbelly
PBPB
$1.96M 0.02%
151,061
-278,439
-65% -$3.51M
NCNA
354
NuCana
NCNA
$6.12M
$1.95M 0.02%
20
TECD
355
DELISTED
Tech Data Corp
TECD
$1.93M 0.02%
+23,516
New +$1.94M
FSAC
356
CALL
DELISTED
Federal Street Acquisition Corp. Common Stock
FSAC
$1.92M 0.02%
1,500,001
STIM icon
357
Neuronetics
STIM
$166M
$1.86M 0.02%
+70,000
New +$1.9M
ALDR
358
DELISTED
Alder Biopharmaceuticals
ALDR
$1.81M 0.02%
114,528
+53,663
+88% +$815K
GILD icon
359
Gilead Sciences
GILD
$165B
$1.75M 0.02%
24,658
-1,165,501
-98% -$82.3M
VEAC
360
CALL
DELISTED
Vantage Energy Acquisition Corp. Class A
VEAC
$1.73M 0.02%
1,333,334
ITT icon
361
ITT
ITT
$19.1B
$1.72M 0.02%
+32,889
New +$1.72M
MGTX icon
362
MeiraGTx Holdings
MGTX
$1.21B
$1.72M 0.02%
+150,000
New +$2.01M
USWS
363
CALL
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$1.68M 0.02%
119,048
ACER
364
DELISTED
Acer Therapeutics Inc
ACER
$1.64M 0.01%
76,009
-13,389
-15% -$254K
VCEL icon
365
Vericel Corp
VCEL
$2.31B
$1.62M 0.01%
+167,421
New +$2.09M
FOLD
366
DELISTED
Amicus Therapeutics
FOLD
$1.61M 0.01%
103,304
+3,304
+3% +$49.9K
FTSV
367
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$1.6M 0.01%
+100,000
New +$1.55M
ATHN
368
DELISTED
Athenahealth, Inc.
ATHN
$1.59M 0.01%
+10,011
New +$1.48M
NTGN
369
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$1.57M 0.01%
+125,000
New +$1.71M
CARM
370
DELISTED
Carisma Therapeutics
CARM
$1.48M 0.01%
+38,023
New +$1.68M
KNSA icon
371
Kiniksa Pharmaceuticals
KNSA
$5.93B
$1.46M 0.01%
+84,313
New +$1.53M
LJPC
372
DELISTED
La Jolla Pharmaceutical Company
LJPC
$1.46M 0.01%
50,000
+28,925
+137% +$893K
SNAP icon
373
Snap
SNAP
$9.01B
$1.4M 0.01%
+106,843
New +$1.38M
VRCA icon
374
Verrica Pharmaceuticals
VRCA
$87.3M
$1.38M 0.01%
+7,005
New +$1.37M
HPE icon
375
Hewlett Packard
HPE
$70.5B
$1.38M 0.01%
94,429
-984,140
-91% -$16.3M

Similar funds

Alyeska Investment Group's Q2 2018 Portfolio in Review

As of Q2 2018, Alyeska Investment Group held 603 positions worth $11.2B, down 7.7% from $12.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group withdrew a net $880M in Q2 2018, closing 159 positions and reducing 122 holdings. Its most notable exit was IBM, an estimated $155M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Energy.

Against the trend, Alyeska Investment Group opened a new position in Skyworks Solutions worth $122M.

  • Alyeska Investment Group's largest Q2 2018 buy was Skyworks Solutions: 1,261,692 shares worth $122M.
  • Alyeska Investment Group added most to Alphabet (Google) Class A in Q2 2018, an estimated $142M increase.
  • Alyeska Investment Group's biggest Q2 2018 reduction was Salesforce, cutting an estimated $124M.
  • Alyeska Investment Group fully exited IBM in Q2 2018, selling an estimated $155M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $11.2B portfolio in Q2 2018.
  • Alyeska Investment Group opened 165 new positions and closed 159 in Q2 2018.
  • Alyeska Investment Group's portfolio value fell 7.7% quarter-over-quarter to $11.2B.

Based on Alyeska Investment Group's 13F filing for Q2 2018, filed 14 Aug 2018.